+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Faropenem Sodium Market by Form, Route of Administration, Treatment Indication, Distribution Channel, End User, Dosage Strength - Global Forecast to 2030- Product Image
Faropenem Sodium Market by Form, Route of Administration, Treatment Indication, Distribution Channel, End User, Dosage Strength - Global Forecast to 2030- Product Image
Sale

Faropenem Sodium Market by Form, Route of Administration, Treatment Indication, Distribution Channel, End User, Dosage Strength - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454934
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Faropenem sodium is increasingly recognized as a key solution in the fight against multi-drug resistance, placing it at the forefront of antimicrobial innovation and adoption within global healthcare systems. Senior decision-makers seeking actionable intelligence on growth, regional dynamics, and competitive positioning will find this analysis essential for informed strategy.

Market Snapshot: Faropenem Sodium Market

The Faropenem Sodium Market grew from USD 236.54 million in 2024 to USD 259.51 million in 2025. It is expected to continue growing at a CAGR of 9.26%, reaching USD 402.52 million by 2030. This strong upward trajectory is driven by increasing demand for effective antibiotics capable of addressing resistant infections, along with adaptable delivery formats that support both inpatient and outpatient care. Adoption is influenced by the dual availability of intravenous and oral formulations, offering flexibility and broad clinical utility. Stakeholders are recalibrating supply chain and distribution strategies amid evolving global regulatory environments and expanding indications.

Scope & Segmentation

This comprehensive report provides detailed segmentation, highlighting all factors relevant to a robust growth strategy:

  • Form Types: Capsules, granules, solution for injection, tablets
  • Routes of Administration: Intravenous, oral
  • Treatment Indications: Intra abdominal infections, respiratory infections, skin and soft tissue infections, urinary tract infections
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • End Users: Ambulatory care centers, clinics, hospitals
  • Dosage Strengths: 50 mg, 100 mg, 150 mg, 200 mg
  • Regions & Markets: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), and Asia-Pacific (including China, India, Japan, and additional countries)
  • Key Industry Participants: Shionogi & Co., Ltd, Meiji Seika Pharma Co., Ltd, Lupin Limited, Zydus Lifesciences Limited, Cipla Limited, Alembic Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Dr. Reddy's Laboratories Limited, Aurobindo Pharma Limited, Sandoz International GmbH

Key Takeaways for Senior Stakeholders

  • The market is experiencing robust expansion due to rising concerns about antibiotic resistance, with faropenem sodium standing out for its stability and clinical versatility.
  • Integrated oral and intravenous formulations are driving seamless patient transitions between acute and home-based care, supporting healthcare optimization strategies.
  • Regulatory harmonization, especially in Europe, the Middle East, and Africa, is streamlining approvals but often requires additional local evidence to account for region-specific epidemiology.
  • Strategic alliances—spanning CDMOs, digital health vendors, and academic centers—are strengthening competitive positioning while facilitating product differentiation through enhanced adherence monitoring and combination therapies.
  • Market entry strategies benefit from targeted supply chain resilience, especially in response to volatility caused by global trade conditions and evolving tariff landscapes.
  • Diversified segmentation enables highly tailored go-to-market approaches, with dosage and delivery flexibility aligning closely to variable patient needs and stewardship priorities.

Impact of US Tariffs on Faropenem Sodium (2025)

The imposition of new United States tariffs in 2025 has introduced cost pressures across the supply chain for faropenem sodium. Manufacturers dependent on imported raw materials are encountering increased duties that compress margins and require contractual renegotiations. In response, some industry leaders are securing domestic production capacity to mitigate tariff impact, while downstream stakeholders—including wholesalers, distributors, and healthcare providers—are adjusting procurement and pricing models. In the short term, these dynamics are prompting hospitals and outpatient centers to reassess formulary priorities, with collective purchasing initiatives helping to counter pricing volatility and maintain patient access.

Methodology & Data Sources

This report’s findings are based on a systematic review of peer-reviewed literature, regulatory filings, patent databases, and primary interviews with key opinion leaders, supply chain leaders, and formulary stakeholders. Proprietary trade reports, tariff schedules, and manufacturer financial disclosures were triangulated for data validation.

Why This Report Matters

  • Enables strategic supply chain planning and proactive risk mitigation in response to shifting regulations and tariffs.
  • Provides detailed segmentation and regional insights to support targeted growth initiatives and optimize formulary expansion.
  • Equips decision-makers with actionable intelligence for effective stakeholder engagement and competitive differentiation within the faropenem sodium segment.

Conclusion

The Faropenem Sodium Market continues its pivotal role in advancing antimicrobial therapy and stewardship. Detailed segmentation and supply chain insights offer decision-makers the foundation to make informed, resilient choices. Sustained investment in clinical evidence and strategic partnerships will be crucial for long-term leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Faropenem Sodium Market, by Form
8.1. Introduction
8.2. Capsules
8.3. Granules
8.4. Solution For Injection
8.5. Tablets
9. Faropenem Sodium Market, by Route of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
10. Faropenem Sodium Market, by Treatment Indication
10.1. Introduction
10.2. Intra Abdominal Infections
10.3. Respiratory Infections
10.4. Skin and Soft Tissue Infections
10.5. Urinary Tract Infections
11. Faropenem Sodium Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Faropenem Sodium Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Hospitals
13. Faropenem Sodium Market, by Dosage Strength
13.1. Introduction
13.2. 100Mg
13.3. 150Mg
13.4. 200Mg
13.5. 50Mg
14. Americas Faropenem Sodium Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Faropenem Sodium Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Faropenem Sodium Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Shionogi & Co., Ltd
17.3.2. Meiji Seika Pharma Co., Ltd
17.3.3. Lupin Limited
17.3.4. Zydus Lifesciences Limited
17.3.5. Cipla Limited
17.3.6. Alembic Pharmaceuticals Limited
17.3.7. Glenmark Pharmaceuticals Limited
17.3.8. Dr. Reddy's Laboratories Limited
17.3.9. Aurobindo Pharma Limited
17.3.10. Sandoz International GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. FAROPENEM SODIUM MARKET MULTI-CURRENCY
FIGURE 2. FAROPENEM SODIUM MARKET MULTI-LANGUAGE
FIGURE 3. FAROPENEM SODIUM MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FAROPENEM SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. FAROPENEM SODIUM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. FAROPENEM SODIUM MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FAROPENEM SODIUM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FAROPENEM SODIUM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY SOLUTION FOR INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY INTRA ABDOMINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY 100MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY 150MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY 200MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FAROPENEM SODIUM MARKET SIZE, BY 50MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES FAROPENEM SODIUM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. CANADA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. CANADA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. CANADA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. MEXICO FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MEXICO FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 83. GERMANY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 84. GERMANY FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. GERMANY FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. GERMANY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. GERMANY FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 89. FRANCE FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. FRANCE FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. FRANCE FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 101. ITALY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. ITALY FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. ITALY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ITALY FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 107. SPAIN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. SPAIN FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. SPAIN FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. SPAIN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. SPAIN FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 131. DENMARK FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. DENMARK FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. DENMARK FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. DENMARK FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 143. QATAR FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 144. QATAR FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. QATAR FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. QATAR FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 149. FINLAND FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. FINLAND FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. FINLAND FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. FINLAND FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 167. EGYPT FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. EGYPT FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. EGYPT FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. EGYPT FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 173. TURKEY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 174. TURKEY FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. TURKEY FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 185. NORWAY FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. NORWAY FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. NORWAY FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. NORWAY FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. NORWAY FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 191. POLAND FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. POLAND FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. POLAND FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. POLAND FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. POLAND FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. CHINA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 211. CHINA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. CHINA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. CHINA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. CHINA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 216. INDIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. INDIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. INDIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. INDIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. INDIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 222. JAPAN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 223. JAPAN FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. JAPAN FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. JAPAN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. JAPAN FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 246. THAILAND FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 247. THAILAND FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. THAILAND FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. THAILAND FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. THAILAND FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY TREATMENT INDICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN FAROPENEM SODIUM MARKET SIZE, BY DOSAGE STRENGTH, 2018-2030 (USD MILLION)
TABLE 282. FAROPENEM SODIUM MARKET SHARE, BY KEY PLAYER, 2024
TABLE 283. FAROPENEM SODIUM MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Faropenem Sodium market report include:
  • Shionogi & Co., Ltd
  • Meiji Seika Pharma Co., Ltd
  • Lupin Limited
  • Zydus Lifesciences Limited
  • Cipla Limited
  • Alembic Pharmaceuticals Limited
  • Glenmark Pharmaceuticals Limited
  • Dr. Reddy's Laboratories Limited
  • Aurobindo Pharma Limited
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 259.51 Million
Forecasted Market Value ( USD ) by 2030 $ 402.52 Million
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Sodium Borohydride Market by Application, End Use Industry, Form, Purity Grade, Sales Channel - Global Forecast to 2030 - Product Image

Sodium Borohydride Market by Application, End Use Industry, Form, Purity Grade, Sales Channel - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Persulfates Market by Product Type, Applications, Sales Channel, End-Use Industry - Global Forecast to 2030 - Product Image

Persulfates Market by Product Type, Applications, Sales Channel, End-Use Industry - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Sodium Dithiocarbamate Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sodium Dithiocarbamate Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Bispyribac Sodium Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Bispyribac Sodium Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 83 Pages
  • Global
From
Sodium Hydrosulphide Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Sodium Hydrosulphide Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.